# Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01878669` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01878669](<https://clinicaltrials.gov/study/NCT01878669>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01878669

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 390 participants.

## Technical summary

Registry record NCT01878669. Randomized; triple masking; primary purpose prevention. Start 2013-01 (registry gives no type); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 390 participants (planned count; ClinicalTrials.gov record NCT01878669, source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT01878669, source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT01878669, source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT01878669, source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)
- Countries: Türkiye (ClinicalTrials.gov record NCT01878669, source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01878669-2025-05-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
- Acronym: EASE-PCI
- Condition: Coronary Artery Disease
- Intervention (Drug): N-acetyl cysteine
- Intervention (Drug): Saline
- Lead sponsor: Suleyman Demirel University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Suleyman Demirel University (`cardio:org-suleyman-demirel-university`)

## Provenance

Content hash: d8dbefe2646267c740d40aa57873306e2dbb86c34a8f581a487efac73da99ac9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
